Skip to main content

Guardian Unlimited
Go to:  
Guardian UnlimitedThe Guardian
Home UK Business Online World dispatch The Wrap Newsblog Talk Search
The Guardian World News guide Arts Special reports Columnists Audio Help Quiz

UK news
 
  Search this site






  In this section
Fertility clinic planned for lesbian couples

Naked pictures force closure of gallery

Equitable directors snub report

PCs: the latest waste mountain

Shadow cast over boom in online betting

OS maps out the future

Footballers to be told charges they face

Test could cut exam stress for 7-year-olds

Art masterpieces raise 61m at auction

Disgusted of Covent Garden berate the missing maestro

Sir Elton jostles with photographers, but show goes on

MMR vaccinations fall to new low

Physiotherapy doesn't work for back pain, study says

Campaign from heart ignored Whitehall

City responds to plea

Death of son led hostage to Middle East

Hostage drama casts shadow over Blair

Protorosaur which came out of the gloom

Architect forced to cut staff numbers

Abolish BBC governors, says Greg Dyke

Finucane family attack secretive murder inquiry as fiasco and circus

Shaun the sheep to star in own series

Rock climbers threaten prehistoric carvings

Underground staff brought into focus for passengers

FO loses millions on property deals

British Council's logo dots fail to hit the spot

Violence in Ulster drives 1,240 people from homes

Fear of revolts delays hospital shake ups

Reid pledges action on smoking

MoD accused of dragging feet over uranium test for Gulf war veterans

Boy who lets feet do the talking

In brief

BBC drops controversial Pope cartoon

Learn for joy not just jobs says new minister

Air travellers asked to pay CO2 levy

eBay users warned to beware fraudsters

National Gallery's new front entrance

Roy Keane in court on assault charge

U-turn on sale of military fire service

Catholic aid agency advocates condoms

Pupils sent home after racist chants

Study finds dogs can smell cancer

Coronation Street veteran to quit, but not quite yet

Yusuf Islam acts over US 'slur'


Seroxat and Prozac 'can make people homicidal'

Doctor who found suicide risk says experts ignoring danger

Sarah Boseley, health editor
Tuesday September 21, 2004
The Guardian


Evidence that antidepressant drugs like Seroxat and Prozac could make people homicidal is being ignored by the body responsible for regulating medicines in the UK, a leading expert said yesterday.

The charge came from David Healy, an expert on psychiatric drugs from north Wales whose warnings that the drugs could cause suicide prompted a major inquiry. That investigation, by an expert working group of the Medicines and Healthcare Products Regulatory Authority, led to the entire class of drugs except Prozac being banned last year from use in children.

The expert working group has gone on to look at suicides in adults taking any of the drugs known as SSRIs (selective serotonin reuptake inhibitors). But Dr Healy says that they are overlooking very important data relating to a set of further dangerous side-effects.

Dr Healy, director of the north Wales department of psychological medicine, says he has seen data from the clinical trials that show even some healthy volunteers - people with no illness at all volunteering to take part in the earliest safety trials of the drugs - became unaccountably aggressive. Their reaction is coded as "hostile" which can include homicidal behaviour and serious aggression.

"I think there is very clear evidence for all of the SSRI group of drugs that in addition to making people suicidal, they can make people homicidal or seriously aggressive and the data have been sitting in the MHRA's files on this issue," he said.

"It is there for children across a range of different problems, it is there for healthy volunteers and a range of adults and the MHRA has paid no heed to this."

The healthy volunteer trials of the British drug Seroxat took place in the late 1980s or early 1990s. Of the 271 fit and well individuals, three became hostile, compared with none on an inactive placebo - a rate of 1.1%, which although small could translate to very many cases among the 50m worldwide who have taken Seroxat over the last 15 years.

The signal from the healthy volunteer trials is supported by data from trials in children on Seroxat for obsessive compulsive disorder (OCD), depression and social phobia. Children taking part amounted to 738 on Seroxat and 647 on placebo. Of those, there were 27 hostile events on Seroxat and only four on placebo. Taking the children with OCD alone, those on the drug were 17 times more likely to become aggressive than those on placebo.

Trials of Seroxat (known generically as paroxetine) for women with pre-menstrual syndrome show a similar pattern, with five hostile acts on the drug and none on placebo.

But, says Dr Healy, the MHRA officials appear not to have picked up the signals from all the separate trials and are failing to see the whole picture.

A number of cases where people have argued their aggressive acts were due to one of the SSRI antidepressants have come to court. In the most dramatic, a US jury in 2001 found that GlaxoSmithKline's drug was partly responsible for the murders committed by Donald Schell. After two days on Paxil (as Seroxat is named in the USA), Schell killed his wife, his daughter and his baby granddaughter before shooting himself dead. GlaxoSmithKline was ordered to pay $8m (4.5m) to the remaining family members.

GlaxoSmithKline last night denied that its drug caused adults to become hostile, although it acknowledged there had been a problem in the children's trials. "There is no compelling evidence from our clinical trials that Seroxat causes hostile behaviour in adults. When you put the results from all the clinical trials together there is no difference between the rates of hostility for adult patients taking Seroxat and the patients taking placebo, or dummy pill. This data has been shared with regulators including the MHRA," said a spokesman.

The MHRA said yesterday that the working group had looked at the data on events coded as "hostility" in its analysis of the children's trials and that it had acted to prevent the use of most SSRIs in children as a result of all the data, including that on hostility. "The review of adult data is ongoing," it said.


Be in the know
Sign up for our email bulletins

Related articles
19.06.2004: Glaxo changes tack after Spitzer assault
03.06.2004: Glaxo faces drug fraud lawsuit
14.06.2004: Safety alert on adult use of antidepressants
23.04.2004: SSRI dangers for children 'suppressed'

Big issues
Mental health

Glossary
A-Z guide to public services and voluntary sector speak

Useful sites
European Agency for the Evaluation of Medicinal Products
Medicines and Healthcare Regulatory Agency
Mind
GlaxoSmithKline
The medicines and healthcare products regulatory agency
Department of Health: mental health
Depression Alliance
The Royal College of Psychiatrists
Institute of Psychiatry




Printable version | Send it to a friend | Save story

 
 



UP

Guardian Unlimited Guardian Newspapers Limited 2004